Molecular genetic events in gastrointestinal and pancreatic neuroendocrine tumors.
Gastrointestinal and pancreatic neuroendocrine tumors originate from the cells of the diffuse endocrine system. Their molecular genetic mechanism of development and progression is complex and remains largely unknown, and they are different in genetic composition from the gastrointestinal epithelial tumors. The current literature suggests that multiple genes are involved in their tumorigenesis with significant differences for tumors of different embryological derivatives: foregut, midgut and hindgut. The MEN1 gene is involved in initiation of 33% of foregut gastrointestinal neuroendocrine tumors. 18q defects are present almost exclusively in mid/hindgut neuroendocrine tumors. X-chromosome markers are associated with malignant behavior in foregut tumors only. Analysis of poorly differentiated neuroendocrine carcinomas of any site demonstrates high chromosomal instability and frequent p53 alterations similar to other poorly differentiated carcinomas. Several factors played a limiting role in the molecular studies published to date: the tumors are rare and heterogeneous, it is difficult to predict their behavior and prognosis, and several different tumor classifications are used by the investigators in the studies. Future studies need to evaluate molecular genetic composition of large series of gastrointestinal and pancreatic neuroendocrine tumors of each specific tumor type. Understanding of specific genetic alterations characteristic for gastrointestinal and pancreatic neuroendocrine tumors might lead to their improved diagnosis, morphologic and molecular characterization and treatment.
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis National Cancer Institute, National Institutes of Health, 6130 Executive Blvd, EPN 6032, Rockville, MD 20892, USA. lubenskyi@mail.nih.gov
Irina A
IA
Lubensky
Zhengping
Z
Zhuang
D043171:Chromosomal Instability / Q000502:physiology; D005770:Gastrointestinal Neoplasms / Q000235:genetics*; D041981:Gastrointestinal Tract / Q000196:embryology / Q000254:growth & development / Q000378:metabolism; D052138:Genes, Neoplasm / Q000502:physiology; D005819:Genetic Markers / Q000502:physiology; D006801:Humans; D019656:Loss of Heterozygosity / Q000502:physiology; D009154:Mutation / Q000502:physiology; D018358:Neuroendocrine Tumors / Q000235:genetics*; D010179:Pancreas / Q000196:embryology / Q000254:growth & development / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000235:genetics*
D005819:Genetic Markers